NCT06720766View on ClinicalTrials.gov

Assessment of FibbroScan in Diagnosing MASLD Among the Chinese Population With Obesity

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

October 24, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Fatty Liver Disease
Interventions
DIAGNOSTIC_TEST

FibbroScan and biopsy

In individuals with obesity, a biopsy is performed within a week after undergoing an FibroScan examination.

Trial Locations (1)

Unknown

RECRUITING

The Third People's Hospital of Chengdu, Chengdu

All Listed Sponsors
lead

The Third People's Hospital of Chengdu

OTHER